Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Giant Cell Myocarditis
Welcome,
Profile
Billing
Logout
2 Companies
3 Products
3 Products
1 Mechanism of Action
0 Trials
2 News
|
|||||||||
Orthoclone OKT3
(muromonab-CD3) /
J&J
Trial completion, Trial completion date:
Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis
(clinicaltrials.gov) - Mar 25, 2015
P=N/A
, N=40, Completed,
Sponsor: Mayo Clinic
Recruiting --> Completed | Trial completion date: Jul 2004 --> Jul 2007
|
|||||||||
Orthoclone OKT3
(muromonab-CD3) /
J&J
Trial completion:
Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
(clinicaltrials.gov) - Feb 19, 2014
P2
, N=40, Completed,
Sponsor: Mayo Clinic
Recruiting --> Completed | Trial completion date: Jul 2004 --> Jul 2007 No longer recruiting --> Completed